Published in Dev Biol Stand on January 01, 1985
New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J Clin Microbiol (2000) 2.27
Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis. Thorax (2009) 1.78
Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis. Thorax (2003) 1.50
The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox Sang (1979) 1.31
Tell me what you mean by "sí": perceptions of quality of prenatal care among immigrant Latina women. Qual Health Res (2001) 1.12
Simulation of animal cell metabolism. Cytotechnology (1992) 1.09
Motor processes in simple, go/no-go, and choice reaction time tasks: a psychophysiological analysis. J Exp Psychol Hum Percept Perform (2001) 1.02
Nasal carriage of Staphylococcus aureus in Australian (pre-clinical and clinical) medical students. J Hosp Infect (1994) 0.91
Method for detection of respiratory viruses in the sputa of patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2005) 0.91
Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis. Eur J Clin Microbiol Infect Dis (2013) 0.89
Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clin Microbiol Infect (2012) 0.88
Prevalence of peritonitis-associated coagulase-negative staphylococci on the skin of continuous ambulatory peritoneal dialysis patients. Epidemiol Infect (1989) 0.88
Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations. Dev Biol Stand (1985) 0.84
Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol Motil (2011) 0.83
Rapid detection of non-multidrug-resistant and multidrug-resistant methicillin-resistant Staphylococcus aureus using cycling probe technology for the mecA gene. Eur J Clin Microbiol Infect Dis (2003) 0.82
Factors affecting hepatocyte viability and CYPIA1 activity during encapsulation. Artif Cells Blood Substit Immobil Biotechnol (2000) 0.82
Characterization of hemolysin of Moraxella bovis using a hemolysis-neutralizing monoclonal antibody. Infect Immun (2000) 0.79
Reinfusion drains after primary total hip and total knee arthroplasty. J South Orthop Assoc (2000) 0.79
Professional and voluntary blood: a preliminary study in Iran. Vox Sang (1978) 0.79
Amino acid metabolism during batch culture of a murine hybridoma, AFP-27. Cytotechnology (1996) 0.78
New screening medium for detection and identification of methicillin/oxacillin-resistant Staphylococcus aureus for nosocomial surveillance. Eur J Clin Microbiol Infect Dis (2002) 0.78
Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column. Biomed Chromatogr (2001) 0.78
Carbohydrate and amino acid metabolism during batch culture of a human lymphoblastoid cell line, BTSN6. Cytotechnology (1996) 0.78
A study of coagulase-negative staphylococci isolated from clinically significant infections at an Australian teaching hospital. Pathology (1989) 0.77
Expression of blood group antigens by cultured human epidermal cells. J Invest Dermatol (1986) 0.77
Biosynthesis of protein products by animal cells. Are growth and non-growth associated concepts valid or useful? Cytotechnology (1996) 0.77
Analysis of multivariables during porcine liver digestion to improve hepatocyte yield and viability for use in bioartificial liver support systems. Cell Transplant (2000) 0.76
An analysis of some batch and continuous kinetic data of specific monoclonal antibody production from hybridomas. Cytotechnology (1991) 0.76
Blood grouping with monoclonal anti-N antibodies. Aust J Exp Biol Med Sci (1986) 0.76
Serological typing of coagulase-negative staphylococci using monoclonal antibodies. Epidemiol Infect (1991) 0.75
Cellular and plasma-associated phagocytic defects amongst Iranian blood donors. Vox Sang (1978) 0.75
A comparison of different culture methods for hybridoma propagation and monoclonal antibody production. Cytotechnology (1990) 0.75
The removal of model viruses, poliovirus type 1 and canine parvovirus, during the purification of human albumin using ion-exchange chromatographic procedures. Biologicals (1997) 0.75
Agitation and aeration effects in suspension mammalian cell cultures. Cytotechnology (1989) 0.75
Anatomy of the knee extensor mechanism: correlation with patellofemoral arthrosis. J South Orthop Assoc (2001) 0.75
Monoclonal antibodies specific for blood groups A and B. Aust J Exp Biol Med Sci (1984) 0.75
Infant hearing screening: program implementation and validation. Ear Hear (1987) 0.75
Cell-mediated immunity in professional and voluntary blood donors. Vox Sang (1978) 0.75
Introduction. Cytotechnology (1996) 0.75
An interesting monoclonal anti-N produced following immunization with human group O, NN erythrocytes. J Immunogenet (1984) 0.75
Kinetic studies of monoclonal antibody production. Aust J Biotechnol (1990) 0.75
Potential annihilation. Br Dent J (2007) 0.75
Screening for anti-tetanus toxin antibodies in Iran. Rev Fr Transfus Immunohematol (1978) 0.75
Blood grouping with monoclonal antibodies. Dev Biol Stand (1987) 0.75
Process development for hybridoma cells. Adv Biochem Eng Biotechnol (1988) 0.75
Some physiological concomitants of pursuit rotor performance and reminiscence. J Mot Behav (1969) 0.75
Responsible approach to safe intoxicant use needed in age of reason. Can Pharm J (1982) 0.75
Monoclonal antibodies to 2,4-dichlorophenol hydroxylase as probes for the 2,4-D-degradative phenotype. Can J Microbiol (1998) 0.75
Glycosylation and functional activity of anti-D secreted by two human lymphoblastoid cell lines. Cytotechnology (1994) 0.75